Arthramid for
Equine

Arthramid can be used in any synovial joint showing signs of osteoarthritis, including
pain, swelling, reduced range of motion, or lameness confirmed by diagnostic imaging
like X-rays, ultrasound, or MRI. It is effective in both early stages (e.g., synovitis and
capsular stiffness) and advanced or chronic cases of OA.

Before injection, it is important to review the animal’s medical history, including any
signs of infection, current medications, recent surgeries, or fractures, to ensure safe
and appropriate use.

Arthramid comes in prefilled sterile 1 mL syringes, sealed via Luer lock fitting. Arthramid should be administered via a sterile 18-23g needle using aseptic injection technique protocols.

After treatment, rest the horse for 48 hours and plan a reduced-impact workload for up to 2 weeks to allow full integration of the 2.5% iPAAG. A follow-up examination at 4 to 6 weeks is advised to assess the response, with a top-up dose administered if needed.
Horses often show gradual improvement in lameness within the first week, with continued progress over the following weeks. Repeat doses of Arthramid can be safely given every 6 to 12 months if required and clinically indicated.

Arthramid is for intra-articular injection only. The dose may vary depending on the severity of disease, the size of the joint and the duration of clinical signs. The following recommendations have been made based on observed clinical responses to treatment.

Distal Interphalangeal: 1-2mL
Proximal Interphalangeal: 1 mL
Metacarpo/Tarso-phalangeal: 2 mL
Carpus: 2-3mL
Tarsometatarsal/ Distal Intertarsal: 1 mL
Tarsocrural: 2-3 mL
Shoulder: 2-3 mL
Stifles: 2-3 mL per compartment

Arthramid must be stored protected from direct sunlight at room temperature (below 25 degrees Celsius). Do not freeze. Do not store unsealed syringes for later use. Arthramid has a 3-year shelf life from date of manufacture; always check package expiration date before use.